China Universal Asset Management Co., Ltd. Alx Oncology Holdings Inc Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

A detailed history of China Universal Asset Management Co., Ltd. transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 10,130 shares of ALXO stock, worth $18,537. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,130

Previous 6,122 65.47%

Holding current value

$18,537

Previous $36,000 50.0%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$1.81 - $8.13 $7,254 - $32,585	4,008 Added 65.47%	10,130 $18,000
Q2 2024 Jul 19, 2024	SELL	$5.84 - $17.56 $20,235 - $60,845	-3,465 Reduced 36.14%	6,122 $36,000
Q1 2024 Apr 29, 2024	BUY	$10.95 - $16.79 $41,883 - $64,221	3,825 Added 66.38%	9,587 $107,000
Q4 2023 May 21, 2024	SELL	$4.81 - $15.38 $18,398 - $58,828	-3,825 Reduced 39.9%	5,762 $85,000
Q4 2023 Jan 23, 2024	BUY	$4.81 - $15.38 $22,635 - $72,378	4,706 Added 445.64%	5,762 $86,000
Q3 2023 May 21, 2024	BUY	$4.19 - $7.35 $2,178 - $3,822	520 Added 97.01%	1,056 $5,000
Q3 2023 Oct 30, 2023	BUY	$4.19 - $7.35 $2,178 - $3,822	520 Added 97.01%	1,056 $5,000
Q2 2023 May 21, 2024	SELL	$4.37 - $9.56 $69 - $152	-16 Reduced 2.9%	536 $4,000
Q2 2023 Jul 27, 2023	SELL	$4.37 - $9.56 $69 - $152	-16 Reduced 2.9%	536 $4,000
Q1 2023 May 21, 2024	BUY	$4.52 - $11.71 $623 - $1,615	138 Added 33.33%	552 $2,000
Q1 2023 Apr 27, 2023	BUY	$4.52 - $11.71 $623 - $1,615	138 Added 33.33%	552 $2,000
Q4 2022 May 21, 2024	SELL	$9.51 - $12.95 $87,235 - $118,790	-9,173 Reduced 95.68%	414 $4,000
Q4 2022 Jan 31, 2023	BUY	$9.51 - $12.95 $304 - $414	32 Added 8.38%	414 $5,000
Q3 2022 Oct 21, 2022	BUY	$8.23 - $15.14 $3,143 - $5,783	382 New	382 $4,000

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $74.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account

China Universal Asset Management Co., Ltd. Alx Oncology Holdings Inc Transaction History